We are live on ! Find out more
SG Americas Securities

SG Americas Securities Portfolio holdings

AUM $92.9B
1-Year Est. Return 36.98%
This Fund
S&P 500
This Quarter Est. Return
+18.25%
1 Year Est. Return
+36.98%
3 Year Est. Return
+96.33%
5 Year Est. Return
+110.18%
10 Year Est. Return
+436.29%
AUM
$18.7B
AUM Growth
+$3.02B
Cap. Flow
+$1.48B
Cap. Flow %
7.88%
Top 10 Hldgs %
25.87%
Holding
3,577
New
944
Increased
1,216
Reduced
820
Closed
266

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$267M
2
ZM icon
Zoom
ZM
+$235M
3
CRM icon
Salesforce
CRM
+$180M
4
AMZN icon
Amazon
AMZN
+$178M
5
SDY icon
State Street SPDR S&P Dividend ETF
SDY
+$149M

Sector Composition

Rank Sector Weight
1 Technology 14.1%
2 Consumer Discretionary 10.7%
3 Healthcare 5.69%
4 Communication Services 5.52%
5 Financials 4.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
W icon
3026
CALL
Wayfair
W
$15.3B
$57K ﹤0.01%
+81,000
New +$21.5M
CBIO
3027
Crescent Biopharma
CBIO
$608M
$55K ﹤0.01%
+147
New +$51.5K
YARW
3028
Yarrow Bioscience, Inc. Common Stock
YARW
$25.3M
$55K ﹤0.01%
+10
New +$62.8K
BKR icon
3029
PUT
Baker Hughes
BKR
$61.3B
$54K ﹤0.01%
25,000
COF icon
3030
PUT
Capital One
COF
$136B
$54K ﹤0.01%
80,000
MRK icon
3031
CALL
Merck
MRK
$316B
$54K ﹤0.01%
416,370
+33,850
+9% +$2.59M
DVAX
3032
DELISTED
Dynavax Technologies
DVAX
$53K ﹤0.01%
11,930
-132,370
-92% -$599K
TXMD icon
3033
TherapeuticsMD
TXMD
$23.6M
$53K ﹤0.01%
+872
New +$59.5K
ATRS
3034
DELISTED
Antares Pharma, Inc.
ATRS
$53K ﹤0.01%
13,199
-92,872
-88% -$300K
AKBA icon
3035
Akebia Therapeutics
AKBA
$354M
$52K ﹤0.01%
18,496
-214,366
-92% -$626K
ACTG icon
3036
Acacia Research
ACTG
$445M
$50K ﹤0.01%
+12,677
New +$45.5K
RGR icon
3037
PUT
Sturm, Ruger & Co
RGR
$625M
$50K ﹤0.01%
+26,800
New +$1.72M
AGEN
3038
Agenus
AGEN
$346M
$49K ﹤0.01%
782
-779
-50% -$57.8K
BNY
3039
PUT
Bank of New York Mellon
BNY
$106B
$49K ﹤0.01%
20,000
-48,500
-71% -$1.86M
BNED icon
3040
Barnes & Noble Education
BNED
$447M
$49K ﹤0.01%
+104
New +$34.4K
XP icon
3041
CALL
XP
XP
$8.77B
$49K ﹤0.01%
+54,500
New +$2.23M
CMRX
3042
DELISTED
Chimerix, Inc.
CMRX
$49K ﹤0.01%
+10,124
New +$36.7K
RNAC icon
3043
Cartesian Therapeutics
RNAC
$237M
$48K ﹤0.01%
+529
New +$45.9K
BRY
3044
DELISTED
Berry Corp
BRY
$47K ﹤0.01%
+12,657
New +$43.8K
NCMI icon
3045
National CineMedia
NCMI
$388M
$47K ﹤0.01%
+1,269
New +$38.6K
BBD icon
3046
PUT
Banco Bradesco
BBD
$37.9B
$46K ﹤0.01%
363,000
WTI icon
3047
W&T Offshore
WTI
$509M
$46K ﹤0.01%
+21,095
New +$40.7K
ADMA icon
3048
ADMA Biologics
ADMA
$2.07B
$45K ﹤0.01%
+23,210
New +$48.8K
ELV icon
3049
CALL
Elevance Health
ELV
$82B
$44K ﹤0.01%
28,700
EVC icon
3050
Entravision Communication
EVC
$1.07B
$44K ﹤0.01%
+15,897
New +$38.4K

Similar funds

SG Americas Securities's Q4 2020 Portfolio in Review

As of Q4 2020, SG Americas Securities held 3,577 positions worth $18.7B, up 19% from $15.7B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

SG Americas Securities deployed $1.48B of net new capital in Q4 2020, opening 944 new positions and adding to 1,216 existing holdings. Its largest new stake was State Street SPDR S&P Dividend ETF: 1,470,969 shares worth $156M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $259M trimmed.

  • SG Americas Securities's largest Q4 2020 buy was State Street SPDR S&P Dividend ETF: 1,470,969 shares worth $156M.
  • SG Americas Securities added most to Tesla in Q4 2020, an estimated $267M increase.
  • SG Americas Securities's biggest Q4 2020 reduction was Meta Platforms (Facebook), cutting an estimated $259M.
  • SG Americas Securities fully exited iShares MBS ETF in Q4 2020, selling an estimated $19.5M.
  • SG Americas Securities's ten largest holdings make up 26% of its $18.7B portfolio in Q4 2020.
  • SG Americas Securities opened 944 new positions and closed 266 in Q4 2020.
  • SG Americas Securities's portfolio value rose 19% quarter-over-quarter to $18.7B.

Based on SG Americas Securities's 13F filing for Q4 2020, filed 4 Feb 2021.